Tuning MPL signaling to influence hematopoietic stem cell differentiation and inhibit essential thrombocythemia progenitors
Autor(en): | Cui, Lu Moraga, Ignacio Lerbs, Tristan Van Neste, Camille Wilmes, Stephan Tsutsumi, Naotaka Trotman-Grant, Aaron Claudius Gakovic, Milica Andrews, Sarah Gotlib, Jason Darmanis, Spyros Enge, Martin Quake, Stephen Hitchcock, Ian S. Piehler, Jacob Garcia, K. Christopher Wernig, Gerlinde |
Stichwörter: | C-MPL; EXPANSION; hematopoietic stem cells; MEGAKARYOCYTOPOIESIS; megakaryopoiesis; MEMBER; MOLECULAR-CLONING; Multidisciplinary Sciences; MUTATIONS; myeloproliferative neoplasm; RECEPTOR; Science & Technology - Other Topics; STIMULATION; THROMBOCYTOPENIA; THROMBOPOIETIN; thrombopoietin signaling | Erscheinungsdatum: | 2021 | Herausgeber: | NATL ACAD SCIENCES | Journal: | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | Volumen: | 118 | Ausgabe: | 2 | Zusammenfassung: | Thrombopoietin (TPO) and the TPO-receptor (TPO-R, or c-MPL) are essential for hematopoietic stem cell (HSC) maintenance and megakaryocyte differentiation. Agents that can modulate TPO-R signaling are highly desirable for both basic research and clinical utility. We developed a series of surrogate protein ligands for TPO-R, in the form of diabodies (DBs), that homodimerize TPO-R on the cell surface in geometries that are dictated by the DB receptor binding epitope, in effect ``tuning'' downstream signaling responses. These surrogate ligands exhibit diverse pharmacological properties, inducing graded signaling outputs, from full to partial TPO agonism, thus decoupling the dual functions of TPO/TPO-R. Using single-cell RNA sequencing and HSC self-renewal assays we find that partial agonistic diabodies preserved the stem-like properties of cultured HSCs, but also blocked oncogenic colony formation in essential thrombocythemia (ET) through inverse agonism. Our data suggest that dampening downstream TPO signaling is a powerful approach not only for HSC preservation in culture, but also for inhibiting oncogenic signaling through the TPO-R. |
ISSN: | 00278424 | DOI: | 10.1073/pnas.2017849118 |
Zur Langanzeige